|
1
|
Ellwood P, Asher MI, Billo NE, Bissell K,
Chiang CY, Ellwood EM, El-Sony A, García-Marcos L, Mallol J, Marks
GB, et al: The Global Asthma Network rationale and methods for
Phase I global surveillance: Prevalence, severity, management and
risk factors. Eur Respir J. 49:16016052017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prasad B, Nyenhuis SM, Imayama I, Siddiqi
A and Teodorescu M: Asthma and obstructive sleep apnea overlap:
What has the evidence taught Us? Am J Respir Crit Care Med.
201:1345–1357. 2020. View Article : Google Scholar
|
|
3
|
Woodcock A, Vestbo J, Bakerly ND, New J,
Gibson JM, McCorkindale S, Jones R, Collier S, Lay-Flurrie J, Frith
L, et al: Effectiveness of fluticasone furoate plus vilanterol on
asthma control in clinical practice: An open-label, parallel group,
randomised controlled trial. Lancet. 390:2247–2255. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma P, Yi R, Nayak AP, Wang N, Tang F,
Knight MJ, Pan S, Oliver B and Deshpande DA: Bitter taste receptor
agonists mitigate features of allergic asthma in mice. Sci Rep.
7:461662017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Breton JD, Heydet D, Starrs LM, Veldre T
and Ghildyal R: Molecular changes during TGFβ-mediated lung
fibroblast-myofibroblast differentiation: Implication for
glucocorticoid resistance. Physiol Rep. 6:e136692018. View Article : Google Scholar
|
|
6
|
Aquino-Jarquin G: Emerging role of
CRISPR/Cas9 technology for MicroRNAs editing in cancer research.
Cancer Res. 77:6812–6817. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giroux P, Bhajun R, Segard S, Picquenot C,
Charavay C, Desquilles L, Pinna G, Ginestier C, Denis J, Cherradi N
and Guyon L: miRViz: A novel webserver application to visualize and
interpret microRNA datasets. Nucleic Acids Res. 48:W252–W261. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu L, Xu J, Liu J, Zhang H, Sun C, Wang Q,
Shi C, Zhou X, Hua D, Luo W, et al: The novel chromatin
architectural regulator SND1 promotes glioma proliferation and
invasion and predicts the prognosis of patients. Neuro Oncol.
21:742–754. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu G, Li Y, Ma Y, Lu J, Chen Y, Jiang Q,
Qin Q, Zhao L, Huang Q, Luo Z, et al: Long noncoding RNA LINC00511
contributes to breast cancer tumourigenesis and stemness by
inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res.
37:2892018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang CJ, Zhu CC, Xu J, Wang M, Zhao WY,
Liu Q, Zhao G and Zhang ZZ: Correction to: The lncRNA UCA1 promotes
proliferation, migration, immune escape and inhibits apoptosis in
gastric cancer by sponging anti-tumor miRNAs. Mol Cancer.
18:1292019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Du X, Tu Y, Liu S, Zhao P, Bao Z, Li C, Li
J, Pan M and Ji J: LINC00511 contributes to glioblastoma
tumorigenesis and epithelial-mesenchymal transition via
LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop. J Cell Mol
Med. 24:1474–1487. 2020. View Article : Google Scholar
|
|
12
|
Chiba Y and Misawa M: MicroRNAs and their
therapeutic potential for human diseases: MiR-133a and bronchial
smooth muscle hyperresponsiveness in asthma. J Pharmacol Sci.
114:264–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu F, Gong J, Huang W, Wang Z, Wang M,
Yang J, Wu C, Wu Z and Han B: MicroRNA-106b-5p boosts glioma
tumorigensis by targeting multiple tumor suppressor genes.
Oncogene. 33:4813–4822. 2014. View Article : Google Scholar
|
|
14
|
Chen Z, Chen X, Lei T, Gu Y, Gu J, Huang
J, Lu B, Yuan L, Sun M and Wang Z: Integrative analysis of NSCLC
identifies LINC01234 as an oncogenic lncRNA that interacts with
HNRNPA2B1 and regulates miR-106b biogenesis. Mol Ther.
28:1479–1493. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang J, Yin Z, Li Y, Liu Y, Huang G, Gu C
and Fei J: The identification of long non-coding RNA H19 target and
its function in chronic myeloid leukemia. Mol Ther Nucleic Acids.
19:1368–1378. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Z, Li TE, Chen M, Pan JJ and Shen KW:
miR-106b-5p contributes to the lung metastasis of breast cancer via
targeting CNN1 and regulating Rho/ROCK1 pathway. Aging (Albany NY).
12:1867–1887. 2020. View Article : Google Scholar
|
|
17
|
Lee J, Kim HE, Song YS, Cho EY and Lee A:
miR-106b-5p and miR-17-5p could predict recurrence and progression
in breast ductal carcinoma in situ based on the transforming growth
factor-beta pathway. Breast Cancer Res Treat. 176:119–130. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu H, Gu S, Zhang X, Zhang S, Zhang D, Lin
J, Hasengbayi S and Han W: miR-106b-5p promotes aggressive
progression of hepatocellular carcinoma via targeting RUNX3. Cancer
Med. 8:6756–6767. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fornes O, Castro-Mondragon JA, Khan A, van
der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M,
Baranašić D, et al: JASPAR 2020: Update of the open-access database
of transcription factor binding profiles. Nucleic Acids Res.
48:D87–D92. 2020.
|
|
20
|
Feng DD, Cao Q, Zhang DQ, Wu XL, Yang CX,
Chen YF, Yu T, Qi HX and Zhou GP: Transcription factor E2F1
positively regulates interferon regulatory factor 5 expression in
non-small cell lung cancer. OncoTargets Ther. 12:6907–6915. 2019.
View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Young K and Morrison H: Quantifying
microglia morphology from photomicrographs of immunohistochemistry
prepared tissue using imagej. J Vis Exp. 57648:2018.
|
|
23
|
Yang ZC, Yi MJ, Shan YC, Wang C, Ran N,
Jin LY, Fu P, Feng XY, Xu L and Qu ZH: Targeted inhibition of Six1
attenuates allergic airway inflammation and remodeling in asthmatic
mice. Biomed Pharmacother. 84:1820–1825. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Olafsdottir TA, Theodors F, Bjarnadottir
K, Bjornsdottir US, Agustsdottir AB, Stefansson OA, Ivarsdottir EV,
Sigurdsson JK, Benonisdottir S, Eyjolfsson GI, et al: Eighty-eight
variants highlight the role of T cell regulation and airway
remodeling in asthma pathogenesis. Nat Commun. 11:3932020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bertolini F, Carriero V, Bullone M, Sprio
AE, Defilippi I, Sorbello V, Gani F, Di Stefano A, Massimo Luigi
and Ricciardolo F: Correlation of matrix-related airway remodeling
and bradykinin B1 receptor expression with fixed airflow
obstruction in severe asthma. Allergy. Dec 7–2020.Epub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vignola AM, Kips J and Bousquet J: Tissue
remodeling as a feature of persistent asthma. J Allergy Clin
Immunol. 105:1041–1053. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ward C, Pais M, Bish R, Reid D, Feltis B,
Johns D and Walters EH: Airway inflammation, basement membrane
thickening and bronchial hyperresponsiveness in asthma. Thorax.
57:309–316. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hackett TL, Warner SM, Stefanowicz D,
Shaheen F, Pechkovsky DV, Murray LA, Argentieri R, Kicic A, Stick
SM, Bai TR and Knight DA: Induction of epithelial-mesenchymal
transition in primary airway epithelial cells from patients with
asthma by transforming growth factor-beta1. Am J Respir Crit Care
Med. 180:122–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Jia M, Yan X, Cao L, Barnes PJ,
Adcock IM, Huang M and Yao X: Increased neutrophil
gelatinase-associated lipocalin (NGAL) promotes airway remodelling
in chronic obstructive pulmonary disease. Clin Sci (Lond).
131:1147–1159. 2017. View Article : Google Scholar
|
|
30
|
Gorowiec MR, Borthwick LA, Parker SM,
Kirby JA, Saretzki GC and Fisher AJ: Free radical generation
induces epithelial-to-mesenchymal transition in lung epithelium via
a TGF-β1-dependent mechanism. Free Radic Biol Med. 52:1024–1032.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hackett TL: Epithelial-mesenchymal
transition in the pathophysiology of airway remodelling in asthma.
Curr Opin Allergy Clin Immunol. 12:53–59. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ijaz T, Pazdrak K, Kalita M, Konig R,
Choudhary S, Tian B, Boldogh I and Brasier AR: Systems biology
approaches to under-standing epithelial mesenchymal transition
(EMT) in mucosal remodeling and signaling in asthma. World Allergy
Organ J. 7:132014. View Article : Google Scholar
|
|
33
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ito J, Harada N, Nagashima O, Makino F,
Usui Y, Yagita H, Okumura K, Dorscheid DR, Atsuta R, Akiba H and
Takahashi K: Wound-induced TGF-β1 and TGF-β2 enhance airway
epithelial repair via HB-EGF and TGF-α. Biochem Biophys Res Commun.
412:109–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chakir J, Shannon J, Molet S, Fukakusa M,
Elias J, Laviolette M, Boulet LP and Hamid Q: Airway
remodeling-associated mediators in moderate to severe asthma:
Effect of steroids on TGF-beta, IL-11, IL-17, and type I and type
III collagen expression. J Allergy Clin Immunol. 111:1293–1298.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yamaguchi M, Niimi A, Matsumoto H, Ueda T,
Takemura M, Matsuoka H, Jinnai M, Otsuka K, Oguma T, Takeda T, et
al: Sputum levels of transforming growth factor-beta1 in asthma:
Relation to clinical and computed tomography findings. J Investig
Allergol Clin Immunol. 18:202–206. 2008.PubMed/NCBI
|
|
37
|
Warburton D, Schwarz M, Tefft D,
Flores-Delgado G, Anderson KD and Cardoso WV: The molecular basis
of lung morphogenesis. Mech Dev. 92:55–81. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Holgate ST, Davies DE, Puddicombe S,
Richter A, Lackie P, Lordan J and Howarth P: Mechanisms of airway
epithelial damage: Epithelial-mesenchymal interactions in the
pathogenesis of asthma. Eur Respir J Suppl. 44:24s–29s. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Xu N, Xu J, Kong B, Copple B, Guo
GL and Wang L: E2F1 is a novel fibrogenic gene that regulates
cholestatic liver fibrosis through the Egr-1/SHP/EID1 network.
Hepatology. 60:919–930. 2014. View Article : Google Scholar : PubMed/NCBI
|
